Work

Minimal Mutagenesis Resurrects Human Uricase with Attenuated Immunogenicity

Year: 2026
Type: article
Abstract: The human uricase (UOX) gene was pseudogenized during evolution, leaving uric acid as the terminal product of purine metabolism. Heterologous uricases can elicit anti-drug antibodies, which limit their long-term use. Here, we restored activity to a human-pseudogene-derived uricase reference through molecular-evolution-guided rational design. Sequence alignment guided the construction of reversion mutants by overlap-extension PCR and two rounds of combinatorial optimization. Structural modeling and an accelerated co-culture dendritic cell (acDC) assay were used to generate mechanistic hypotheses and compare cytokine responses. Reconstructed activity first appeared in H4 and peaked in H7 (2.03 U/mg). H2-EL, carrying eight substitutions, reached 4.1 U/mg, and the second-round mutant H7-5, with fifteen substitutions, reached 7.14 U/mg. Structural modeling suggested contributions from intra-subunit stabilization, interfacial assembly, active-site modulation, and long-range coupling. Both H7-5 and H2-EL elicited significantly weaker acDC cytokine responses than Aspergillus flavus uricase. H2-EL induced only a marginal IFN-γ elevation above background, whereas IL-2 remained at the negative-control level. Thus, H2-EL combines high catalytic activity with attenuated acDC cytokine responses and a reduced set of eight substitutions. Its clinical immunogenicity remains to be established.
Source: Cells
Language: English
Subfield: Nephrology
Field: Medicine
Open Access status: gold
Estimated APC paid: $3,258
Award: G938250322
OpenAlex ID: W7235231590
FWCI:
Cites: 36
Cited by:
Related to: 10